EUCTR2011-001696-39-DK进行中（未招募）1 期
The inhibitory effect of metformin on gluconeogenesis in relation to polymorphisms in Organic Cation Transporter 1 (OCT1) in healthy volunteers
niversity of Southern Denmark, Clinical Pharmacology0 个研究点开始时间: 2011年6月15日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •inclusion criteria:
- •Age 18-65 years
- •Included in The Pharmacogenomics Biobank of the University of Southern Denmark
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 36
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range 0
排除标准
- •Daily medication
- •Alcohol abuse
- •Breastfeeding
研究者
相似试验
尚未招募
2 期
Metformin in overweight adults with type 1 diabetes mellitusOverweight/obesityMetabolic and Endocrine - DiabetesDiet and Nutrition - ObesityType 1 diabetes mellitusACTRN12612000660886Professor Peter Clifton100
已完成
不适用
The effect of metformin on blood glucose control in patients with type I diabetesutritional, Metabolic, Endocrine: DiabetesNutritional, Metabolic, EndocrineDiabetesISRCTN55324082Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)20
招募中
2 期
Therapeutic effect of metformin in rectal cancerRectal cancer.Malignant neoplasm of rectumIRCT20190726044335N1Shiraz University of Medical Sciences90
进行中（未招募）
不适用
The Effect of Metformin, an insulin-sensitizing drug, on Breast Cancer Primary Prevention: The Plotina Breast Cancer Prevention Randomized, Placebo Controlled Trial - PLOTINABreast cancer chemopreventionEUCTR2009-009921-28-ITISTITUTI FISIOTERAPICI OSPITALIERI
已完成
2 期
Gastrointestinal mechanisms underlying glucose lowering by metformin in type 2 diabetesType 2 diabetes mellitusMetabolic and Endocrine - DiabetesACTRN12617000243314niversity of Adelaide10